Brief: Lifecore Biomedical Announces Cooperation Agreement With 22NW
July 1 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O :
* LIFECORE BIOMEDICAL ANNOUNCES COOPERATION AGREEMENT WITH
22NW
* LIFECORE BIOMEDICAL INC - TO ADD FOUR DIRECTORS TO BOARD
* LIFECORE BIOMEDICAL INC - 22NW SIGNS STANDSTILL AND
SUPPORT
AGREEMENT
* LIFECORE BIOMEDICAL: 22NW WILL WITHDRAW NOTICE OF
NOMINATIONS OF
DIRECTOR CANDIDATES AT 2023 ANNUAL MEETING
Source text for Eikon: ID:nGNX7k8TJf
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results